Red Light Holland Corp (TSE:TRIP) has released an update.
Red Light Holland Corp has announced a partnership with Professor David Nutt and Drug Science to study the effects of psilocybin microdosing using data from their iMicroapp. This research aims to explore the therapeutic potential of psilocybin and support the development of evidence-based regulations for its use. The initiative underscores the company’s dedication to contributing to the understanding of microdosing in a legal and responsible framework.
For further insights into TSE:TRIP stock, check out TipRanks’ Stock Analysis page.
